Competing studies can be a challenge when enrolling patients in clinical trials. But when those studies are conducted by one sponsor, the need to engage with a single patient population can quickly turn into an asset and huge savings.
clinical trial recruitment
In the United States alone, more than 5 million people over age 65 have been diagnosed with Alzheimer’s disease. Today there is still no cure, but there is hope. More than 79 compounds are in clinical development for Alzheimer’s and other cognitive related diseases.
Faced with the challenge of motivating the at-risk population to get free memory testing, one clinical trial site had the novel idea of hosting a free movie and memory screening event.
We’ve entered an age where more people own a mobile device than a toothbrush. As strange and remarkable as that may seem, it presents an unprecedented opportunity for the pharmaceutical industry. Sponsors are quickly learning how to leverage this new level of real-time connectivity to engage patients and improve workflows.
I moved to Boston recently, and I’m still figuring out the lay of the land. Even when I’m sure of my destination, my app usually re-routes me and I sometimes find a shorter way to get there.
The same can be said for clinical trial recruitment strategies. In the summer months, we find that a lot of our clients are re-assessing. How is the study tracking to its milestones? What goals have been communicated to senior management?
Even the most reluctant among us are coming around to social media, with 2.31 billion users now active on social media globally. Still pharmaceutical and biotech companies have been slow to embrace social media for clinical trials. Why?
From long-distance travel to busy schedules, participating in a clinical trial can be very difficult for patients, especially those living with a rare disease. Because of the complexity of rare diseases, patients and their caregivers must often travel long distances to see investigators who treat their unique disorder.
Access to clinical trial information is driving more participation by volunteers, not just patients. This shift is also shining a light on the evolving motivations of clinical trial participants.
Our Patient & Physician Services (PPS) team designs and implements customized patient recruitment and retention programs, call center initiatives, and digital strategies, all in support of clinical trials. These efforts translate into comprehensive, end-to-end clinical trial strategies for our manufacturer partners that often exceed expectations. Check out our latest blog to see how this team surpassed the enrollment deadline for a breast cancer study.
Any good scientist should know that in order to keep up, you must constantly evolve your techniques. That’s especially true in the realm of clinical development, where balancing the challenges of patient-centric clinical trials with increasingly tighter budgets and shorter timelines is paramount to success.
UBC’s experts are here to help. In our free whitepaper, “Nine Evolutions in Clinical Research & Patient Recruitment: A 2016 Preview,” we share an in-depth look at the trends driving clinical trial participation.
It’s hard to foresee the challenges that come with recruiting patients for clinical trials, unless you have extensive expertise to lean on. UBC’s Patient and Physician Services (PPS) team has supported every major MS drug in the clinical pipeline over the last 17 years. We know how to get the right patients at the right sites for your next MS study.